Who Exports Oseltamivir from India — 118 Suppliers Behind a $122.6M Market
India's oseltamivir export market is supplied by 118 active exporters who collectively shipped $122.6M across 2,149 shipments. NATCO PHARMA LIMITED leads with a 18.0% market share, followed by HETERO LABS LIMITED and MSN LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 69.7% of total export value, reflecting a concentrated market structure.
Top Oseltamivir Exporters from India — Ranked by Export Value
NATCO PHARMA LIMITED is the leading oseltamivir exporter from India, holding a 18.0% share of the $122.6M market across 2,149 shipments from 118 exporters. The top 5 suppliers — NATCO PHARMA LIMITED, HETERO LABS LIMITED, MSN LABORATORIES PRIVATE LIMITED, STRIDES PHARMA SCIENCE LIMITED, LUPIN LIMITED — collectively control 69.7% of total export value, indicating a moderately concentrated market. Individual shares are: NATCO PHARMA LIMITED (18.0%), HETERO LABS LIMITED (17.8%), MSN LABORATORIES PRIVATE LIMITED (16.9%), STRIDES PHARMA SCIENCE LIMITED (9.7%), LUPIN LIMITED (7.3%).
Top Oseltamivir Exporters from India
Ranked by export value · 118 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED NAT-OSELTAMIVIR PHOSPHATE 75MG CAPSULESOSELTAMIVIR PHOSPHATE CAPSULES 75 MGNATFLU CAPSULES 75MG 10S(OSELTAMIVIR PHO | $22.1M | 7 | 18.0% |
| 2 | HETERO LABS LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIONAT-OSELTAMIVIR PHOSPHATE 75MG CAPSULESOSELTAMIVIR PHOSPHATE CAPSULES 75 MG | $21.9M | 24 | 17.8% |
| 3 | MSN LABORATORIES PRIVATE LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES 75 MGOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10 | $20.7M | 10 | 16.9% |
| 4 | STRIDES PHARMA SCIENCE LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIONAT-OSELTAMIVIR PHOSPHATE 75MG CAPSULESOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10 | $11.9M | 6 | 9.7% |
| 5 | LUPIN LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES 75 MGOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10 | $9.0M | 4 | 7.3% |
| 6 | ZYDUS LIFESCIENCES LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10OSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG | $7.5M | 1 | 6.1% |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10OSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG | $6.4M | 1 | 5.2% |
| 8 | MACLEODS PHARMACEUTICALS LTD OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIONAT-OSELTAMIVIR PHOSPHATE 75MG CAPSULESOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10 | $6.3M | 12 | 5.1% |
| 9 | ALEMBIC PHARMACEUTICALS LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10OSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG | $4.1M | 1 | 3.3% |
| 10 | AJANTA PHARMA LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10OSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG | $3.4M | 1 | 2.7% |
| 11 | CADILA HEALTHCARE LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10OSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG | $2.4M | 1 | 2.0% |
| 12 | MACLEODS PHARMACEUTICALS LIMITED OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIONAT-OSELTAMIVIR PHOSPHATE 75MG CAPSULESOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10 | $2.3M | 5 | 1.9% |
| 13 | MYLAN LABORATORIES LIMITED OSELTAMIVIR VIATRIS CAP 75MG 10BL NZHARMLESS MEDICINES :- OSELTAMIVIR VIATRIS CAP 75MG 10BL NZCIPLA - OSELTAMIVIR 75MG CAPSULES (OSELT | $1.8M | 2 | 1.5% |
| 14 | CIPLA LIMITED CIPLA - OSELTAMIVIR 75MG CAPSULES (OSELTOSELTAMIVIR CAP 75MG 10BL ZA MY -TAMYGEN75MG | $910.1K | 1 | 0.7% |
| 15 | ALEMBIC PHARMACEUTICALS LTD OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSIOOSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG- 1 X 10OSELTAMIVIR PHOSPHATE CAPSULES USP 75 MG | $342.4K | 1 | 0.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Oseltamivir exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Natco Pharma Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA issued a warning letter citing CGMP violations at the Kothur facility. |
| Glenmark Pharmaceuticals Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA issued a warning letter for CGMP violations at the Pithampur facility. |
| Lupin Limited | Approved | Yes, December 18, 20 | Unknown | 1 | WHO prequalified Linezolid 600mg tablets on December 18, 2018. (extranet.who.int |
| Hetero Labs Limited | Approved | Yes, June 28, 2022 | Unknown | 1 | WHO prequalified Efavirenz/Lamivudine/Tenofovir tablets on June 28, 2022. (extra |
| Amneal Pharmaceuticals Private Limited | Approved | Unknown | Unknown | 1 | FDA approved Pilocarpine Hydrochloride Ophthalmic Solution 1.25% in April 2025. |
| Cipla Limited | Approved | Unknown | Unknown | 1 | FDA approved Acyclovir Cream 5% in May 2025. |
| Mylan Laboratories Limited | Approved | Unknown | Unknown | 1 | FDA approved Levothyroxine Sodium Tablets in June 2019. |
| Strides Pharma Science Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA issued a warning letter citing CGMP violations. |
TransData Nexus reviewed the regulatory standing of 8 leading Oseltamivir exporters from India. 5 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 0 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Oseltamivir sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of Active Pharmaceutical Ingredients (APIs) and bulk drugs. This concentration of expertise and infrastructure makes Hyderabad a pivotal center for the manufacturing of Oseltamivir and other critical medications.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical industry, encompassing over 3,300 pharmaceutical units as of May 29, 2020. This region specializes in the production of formulations, including tablets and capsules, and is home to prominent companies such as Alembic Pharmaceuticals and Torrent Pharmaceuticals. The well-established infrastructure and skilled workforce in this cluster play a crucial role in the formulation and packaging of Oseltamivir for both domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a strategic export gateway for pharmaceutical products. With approximately 929 pharmaceutical units as of May 29, 2020, this region facilitates the efficient distribution of medications like Oseltamivir to global markets. The proximity to major ports and international airports enhances the export capabilities of companies operating in this cluster.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, housing around 555 pharmaceutical units as of May 29, 2020. Attractive tax incentives and supportive government policies have drawn numerous pharmaceutical companies to set up manufacturing facilities here, contributing to the production of various drugs, including Oseltamivir.
5Sourcing Recommendations
- Diversify Supplier Base: While the top five exporters dominate the market, engaging with a broader range of suppliers can mitigate risks associated with over-reliance on a few sources.
- Leverage Regional Strengths: Utilize the specialized capabilities of different pharmaceutical clusters—such as Hyderabad for APIs and Ahmedabad-Vadodara for formulations—to optimize the supply chain.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and facilitate smooth export processes.
- Assess Export Logistics: Evaluate the logistical advantages of manufacturing locations, particularly those in proximity to major ports and export hubs, to enhance distribution efficiency.
By strategically sourcing Oseltamivir from India's diverse pharmaceutical clusters, companies can capitalize on the country's manufacturing strengths and robust export infrastructure.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Oseltamivir exporters from India
Natco Pharma Limited — Natco Pharma secures bid to supply Olaparib in China
In November 2025, Natco Pharma Limited won a bid conducted by the Chinese health ministry to supply Olaparib tablets to Chinese public hospitals. This procurement was part of China's volume-based procurement (VBP) process, which covered 55 drugs across various therapeutic areas. - IMPACT: This regulatory approval may enhance Natco Pharma's market presence in China, potentially influencing its Oseltamivir export strategies.
Impact: This regulatory approval may enhance Natco Pharma's market presence in China, potentially influencing its Oseltamivir export strategies.
Hetero Labs Limited — Hetero Labs wins bid to supply Dapagliflozin in China
In November 2025, Hetero Labs Limited secured a bid to supply Dapagliflozin tablets to Chinese public hospitals. This was part of China's volume-based procurement (VBP) process, which included 55 drugs across multiple therapeutic areas. - IMPACT: This regulatory success could bolster Hetero Labs' position in the Chinese market, potentially affecting its Oseltamivir export dynamics.
Impact: This regulatory success could bolster Hetero Labs' position in the Chinese market, potentially affecting its Oseltamivir export dynamics.
Strides Pharma Science Limited — Strides Pharma merges CDMO and Soft Gelatin businesses
In November 2024, the Mumbai Bench of the National Company Law Tribunal approved a Scheme of Arrangement, resulting in the merger of Strides Pharma Science Limited's identified Contract Development and Manufacturing Operations (CDMO) and Soft Gelatin businesses with another entity. The scheme became effective on November 27, 2024. - IMPACT: This merger may lead to operational efficiencies, potentially impacting Strides Pharma's Oseltamivir production and export capabilities.
Impact: This merger may lead to operational efficiencies, potentially impacting Strides Pharma's Oseltamivir production and export capabilities.
Common Questions — Oseltamivir Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which oseltamivir supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, NATCO PHARMA LIMITED leads with 176 recorded shipments worth $22.1M. HETERO LABS LIMITED (240 shipments) and MSN LABORATORIES PRIVATE LIMITED (245 shipments) are also established high-volume exporters.
Q How many oseltamivir manufacturers are there in India?
India has 118 active oseltamivir exporters with a combined export market of $122.6M across 2,149 shipments to 79 countries. The top 5 suppliers hold 69.7% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for oseltamivir from India?
Average FOB unit price: $3.50 per unit, ranging from $0.01 to $248.25. Average shipment value: $57.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 118 verified Indian exporters of Oseltamivir ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,149 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 79 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,149 Verified Shipments
118 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists